Literature DB >> 33394162

Monocular and binocular visual parameters associated to vision-related quality of life in patients with epiretinal membrane: a prospective cohort.

Raoul Kanav Khanna1,2, Tiphanie Pichard3, Jeremy Pasco4, Marta Dorvault3, Ann-Rose Cook3, Pierre-Jean Pisella3, Sophie Arsene3.   

Abstract

PURPOSE: Binocular visual impairment related to unilateral idiopathic epiretinal membranes (uiERM) and its association with vision-related quality of life (VR-QoL) has not yet been investigated. This study aimed to explore binocular visual parameters (distance binocular best-corrected visual acuity (BCVA), aniseikonia, stereopsis) and VR-QoL in patients with uiERM.
METHODS: We carried out a prospective single-centre cohort study. The following data were collected: VR-QoL (NEI VFQ-25), distance monocular and binocular BCVA, horizontal and vertical metamorphopsia (M-charts test), horizontal and vertical aniseikonia (NAT TEST) and stereoacuity (TNO test). Multiple linear regression analyses were performed to evaluate factors influencing VR-QoL.
RESULTS: Forty-six patients with uiERM and visual complaints were included. Aniseikonia was found in 40 (80%) participants. Stereoacuity was poor (above 120 s of arc) in 46 (100%) participants. Distance monocular BCVA, horizontal metamorphopsia and horizontal aniseikonia were the factors associated with VR-QoL in patients with uiERM.
CONCLUSIONS: In subjects presenting uiERM, aniseikonia is frequently found and stereopsis is constantly impaired. We advocate quantitative testing of metamorphopsia and aniseikonia in addition to BCVA for the assessment of global visual function. Further investigations are needed to evaluate the effect of vitrectomy on these parameters and VR-QoL. TRIAL REGISTRATION: EudraCT Number/ID RCB: 2016-A00252-49.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Aniseikonia; Binocularity; Epiretinal membrane; Quality of life; Stereopsis

Year:  2021        PMID: 33394162     DOI: 10.1007/s00417-020-05064-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Quantification of metamorphopsia in patients with epiretinal membranes.

Authors:  Chota Matsumoto; Eiko Arimura; Sachiko Okuyama; Sonoko Takada; Shigeki Hashimoto; Yoshikazu Shimomura
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

2.  Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery.

Authors:  S M S Ghazi-Nouri; P G Tranos; G S Rubin; Z C Adams; D G Charteris
Journal:  Br J Ophthalmol       Date:  2006-01-18       Impact factor: 4.638

3.  Aniseikonia associated with epiretinal membranes.

Authors:  M Ugarte; T H Williamson
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

4.  Normative Values for Near and Distance Clinical Tests of Stereoacuity.

Authors:  Marianne E F Piano; Laurence P Tidbury; Anna R O'Connor
Journal:  Strabismus       Date:  2016-12

5.  [The "new aniseikonia tests" and its clinical applications (author's transl)].

Authors:  S Awaya; M Sugawara; F Horibe; F Torii
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1982

6.  Photoreceptor function in eyes with macular edema.

Authors:  C W Lardenoye; K Probst; P J DeLint; A Rothova
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-11       Impact factor: 4.799

7.  Correlations between M-CHARTS and PHP findings and subjective perception of metamorphopsia in patients with macular diseases.

Authors:  Eiko Arimura; Chota Matsumoto; Hiroki Nomoto; Shigeki Hashimoto; Sonoko Takada; Sachiko Okuyama; Yoshikazu Shimomura
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

8.  Defining real change in measures of stereoacuity.

Authors:  Wendy E Adams; David A Leske; Sarah R Hatt; Jonathan M Holmes
Journal:  Ophthalmology       Date:  2008-12-16       Impact factor: 12.079

9.  Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma.

Authors:  Jean-Phillipe Nordmann; Muriel Viala; Kate Sullivan; Benoît Arnould; Gilles Berdeaux
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  M-charts as a tool for quantifying metamorphopsia in age-related macular degeneration treated with the bevacizumab injections.

Authors:  Katarzyna Nowomiejska; Agnieszka Oleszczuk; Agnieszka Brzozowska; Andrzej Grzybowski; Katarzyna Ksiazek; Ryszard Maciejewski; Piotr Ksiazek; Anselm Juenemann; Robert Rejdak
Journal:  BMC Ophthalmol       Date:  2013-04-15       Impact factor: 2.209

View more
  3 in total

1.  Influence of postoperative ectopic inner foveal layer on visual function after removal of idiopathic epiretinal membrane.

Authors:  Bo Hee Kim; Dong Ik Kim; Ki Woong Bae; Un Chul Park
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

2.  Long-term functional outcomes and vision-related quality of life after vitrectomy for epiretinal membrane: a prospective cohort study.

Authors:  Raoul Kanav Khanna; Marta Dorvault; Jeremy Pasco; Ann-Rose Cook; Tiphanie Pichard; Marie-Thérèse Marotte; Pierre-Jean Pisella; Sophie Arsene
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

3.  Visual Functions Affecting Vision-Related Quality of Life Following Intravitreal Ranibizumab Therapy for Central Retinal Vein Occlusion.

Authors:  Tomoya Murakami; Fumiki Okamoto; Yoshimi Sugiura; Shohei Morikawa; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  J Clin Med       Date:  2022-07-16       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.